STRS Ohio’s Epizyme, Inc EPZM Stock Holding History

STRS Ohio’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-30,859	Closed	-$256K	–	2362
2021 Q2	$256K	Hold	30,859	–	–	﹤0.01%	1750
2021 Q1	$268K	Hold	30,859	–	–	﹤0.01%	1746
2020 Q4	$335K	Hold	30,859	–	–	﹤0.01%	1622
2020 Q3	$368K	Sell	30,859 -2,100	-6%	-$28.1K	﹤0.01%	1494
2020 Q2	$529K	Buy	+32,959	New	+$575K	﹤0.01%	1271
2019 Q3	–	Sell	-30,614	Closed	-$384K	–	2188
2019 Q2	$384K	Buy	30,614 +17,623	+136%	+$227K	﹤0.01%	1438
2019 Q1	$160K	Hold	12,991	–	–	﹤0.01%	1722
2018 Q4	$80K	Hold	12,991	–	–	﹤0.01%	1800
2018 Q3	$137K	Hold	12,991	–	–	﹤0.01%	1782
2018 Q2	$176K	Hold	12,991	–	–	﹤0.01%	1778
2018 Q1	$230K	Sell	12,991 -19,300	-60%	-$326K	﹤0.01%	1474
2017 Q4	$405K	Hold	32,291	–	–	﹤0.01%	1377
2017 Q3	$615K	Hold	32,291	–	–	﹤0.01%	1276
2017 Q2	$487K	Buy	32,291 +19,300	+149%	+$292K	﹤0.01%	1343
2017 Q1	$222K	Hold	12,991	–	–	﹤0.01%	1512
2016 Q4	$157K	Hold	12,991	–	–	﹤0.01%	1573
2016 Q3	$127K	Hold	12,991	–	–	﹤0.01%	1638
2016 Q2	$133K	Hold	12,991	–	–	﹤0.01%	1643
2016 Q1	$157K	Hold	12,991	–	–	﹤0.01%	1560
2015 Q4	$208K	Hold	12,991	–	–	﹤0.01%	1516
2015 Q3	$167K	Hold	12,991	–	–	﹤0.01%	1560
2015 Q2	$311K	Hold	12,991	–	–	﹤0.01%	1471
2015 Q1	$243K	Hold	12,991	–	–	﹤0.01%	1414
2014 Q4	$245K	Hold	12,991	–	–	﹤0.01%	1403
2014 Q3	$352K	Buy	+12,991	New	+$404K	﹤0.01%	1319
2014 Q1	–	Sell	-9,700	Closed	-$294K	–	1774
2013 Q4	$202K	Buy	9,700 +4,900	+102%	+$142K	﹤0.01%	1459
2013 Q3	$193K	Buy	4,800 +2,000	+71%	+$67.7K	﹤0.01%	1501
2013 Q2	$79K	Buy	+2,800	New	+$71.9K	﹤0.01%	1675

Other funds holding EPZM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

STRS Ohio's EPZM Position: Q3 2021 in Review

STRS Ohio sold out of Epizyme, Inc (EPZM) in Q3 2021, closing a stake of 30,859 shares — an estimated $256K sold.

STRS Ohio first reported a position in EPZM in Q2 2013 and held it in 28 quarters. The position peaked at $615K in Q3 2017. 116 funds tracked by Wall St. Rank hold EPZM as of Q3 2021.

STRS Ohio reported no remaining Epizyme, Inc position as of Q3 2021 after selling out during the quarter.
STRS Ohio sold 30,859 Epizyme, Inc shares in Q3 2021, an estimated $256K.
STRS Ohio first reported a position in Epizyme, Inc in Q2 2013 and held it in 28 quarters.
STRS Ohio's Epizyme, Inc position peaked at $615K in Q3 2017.
116 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.